Expected earnings - Akebia Therapeutics Inc.
Source: US Earnings Reports
Akebia Therapeutics Inc. (AKBA) is expected to report $-0.02 for Q2 2025
Akebia Therapeutics Inc.
NASDAQ: AKBA
AKBA Trading
2.89% G/L:
$1.425 Last:
2,079,511 Volume:
$1.41 Open:
AKBA Latest News
March 03, 2026 08:00:00 am
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
February 26, 2026 07:00:00 am
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
AKBA Stock Data
$399,375,819
257,405,013
0.93%
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
